Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NCK1 | P16333 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL607927 | 0.82 | CYP1A2 (0.71) | ALDH1A1HPGDHSD17B10LMNAKDM4E | |
| SCHEMBL599036 | 0.81 | ALDH1A1 (0.59) | ALDH1A1HPGDHSD17B10LMNAKDM4E | |
| SCHEMBL597341 | 0.79 | CYP1A2 (0.67) | ALDH1A1HPGDHSD17B10LMNAKDM4E | |
| SCHEMBL30286397 | 0.79 | ALDH1A1 (0.55) | ALDH1A1HPGDHSD17B10CYP1A2CYP2A6 | |
| SCHEMBL597682 | 0.79 | ALDH1A1 (0.55) | ALDH1A1HPGDHSD17B10CYP1A2CYP2A6 | |
| SCHEMBL29518590 | 0.76 | ALDH1A1 (0.53) | ALDH1A1HPGDHSD17B10LMNAKDM4E | |
| SCHEMBL598308 | 0.75 | CYP1A2 (0.60) | ALDH1A1HPGDHSD17B10LMNAKDM4E | |
| SCHEMBL28589147 | 0.75 | ALDH1A1 (0.52) | ALDH1A1HPGDHSD17B10LMNAKDM4E | |
| SCHEMBL597732 | 0.73 | CYP1A2 (0.70) | ALDH1A1HPGDHSD17B10LMNAKDM4E | |
| SCHEMBL26330826 | 0.73 | CYP1A2 (0.57) | ALDH1A1HPGDHSD17B10LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | CRYSOPTIX KK | 2011-03-17 | — | — | US | disclosed |
| EP-2260036-A2 | POLYCYCLIC ORGANIC COMPOUNDS, RETARDATION LAYER AND COMPENSATION PANEL ON THEIR BASE | CRYSOPTIX K.K. (JP) | 2010-12-15 | — | — | EP | disclosed |
| WO-2009109782-A2 | POLYCYCLIC ORGANIC COMPOUNDS, RETARDATION LAYER AND COMPENSATION PANEL ON THEIR BASE | CRYSOPTIX K.K. (JP) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | MCM3, CCNA2, CCNB2 | ALDH1A1 4124/4885HPGD 4655/4885HSD17B10 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.